Post by
InkaGold on Jun 09, 2017 1:05pm
Medreleaf Australia
In addition to its Israeli connection, MedReleaf licensed some of its intellectual property in February to an Australian corporation in order to support an application for Australian cannabis cultivation. According to the filing, "MedReleaf, through its subsidiary, MedReleaf Australia, acquired a 10% equity interest in the Australian corporation, which will operate as MedReleaf Australia, if the application is successful." MedReleaf would then earn royalties on the gross revenues of the Australian corporation, with the potential to get additional equity in the Australian corporation.